Ovarian Malignancy Algorithm (ROMA™)

ROMA is a qualitative serum test that combines the results of HE4, CA 125, and menopausal status into a numerical score.

ROMA is used to assist in evaluating whether a pre-menopausal or post-menopausal woman with an ovarian adnexal mass has a high or low probability of finding malignancy on surgery. ROMA is for women who meet the following criteria:

  • Over 18 years of age.
  • Ovarian adnexal mass present for which surgery is planned, but referral is not yet made to an oncologist.

ROMA is not intended to be a screening or stand-alone diagnostic assay and therefore must be interpreted in conjunction with an independent clinical and radiological assessment.

Multi-Factor Authentication (MFA) is the double-lock door for online security that lets you log into your account that has sensitive data of your patients only after passing through two sets of verification processes.

MFA adds an extra layer of security by prompting a second method of authentication alongside the traditional method of signing in with your username and password. This ensures that each login is secure because access will not be granted without your consent.

By asking for an extra verification factor, MFA enhances the security posture of your organization and greatly reduce the odds of data leakages of patient data.

This will close in 0 seconds